Mitral Valve Insufficiency Clinical Trial
Official title:
A Prospective, Multicenter, Objective Performance Criteria Clinical Study to Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR)
To confirm the effectiveness and safety of the transcatheter mitral valve repair system for the treatment of chronic moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after guideline-directed medical treatment.
This study is a prospective, multicenter, objective performance criteria clinical design.Patients are moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after guideline-directed medical treatment. All subjects receive clinical follow-up immediately after procedure, before discharge, 30 days after procedure, 6 months after transfemoral mitral-valve repair, 12 months and 2 yeas,3 years,4 years after Transfemoral mitral-valve repair. The primary outcome is defined as all-cause death and rehospitalization due to heart failure 12 months after Transfemoral mitral-valve repair. The secondary outcomes include:Rate of rehospitalization due to heart failure after operation;Rate of postoperative mitral regurgitation (MR ≤ 2+);Rate of New York Heart Association (NYHA) Function Class I or II after Transfemoral mitral-valve repair;Change in 6 minutes walk test distance;Improvement value of quality of life changes assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ);Echocardiographic changes in left ventricular end diastolic volume (LVEDV) from baseline;Acute procedural success,Acute device success. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03962023 -
Prognostic Impact of Imaging Parameters in Patients With Primary Mitral Insufficiency by Prolapse (COHORTE-IM)
|
||
Withdrawn |
NCT02624960 -
Safety and Performance of the AccuCinch® System
|
N/A | |
Terminated |
NCT02428010 -
Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study
|
N/A | |
Active, not recruiting |
NCT01533883 -
Cardioband Adjustable Annuloplasty System for Minimally Invasive Mitral Valve Repair
|
N/A | |
Unknown status |
NCT01201070 -
Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery
|
Phase 4 | |
Terminated |
NCT00700947 -
Using Beta Blockers to Treat Mitral Regurgitation
|
Phase 1 | |
Completed |
NCT04351984 -
Transcatheter Mitral Valvuloplasty Pilot Study
|
||
Completed |
NCT04231331 -
Ertugliflozin for Functional Mitral Regurgitation
|
Phase 3 | |
Completed |
NCT05742789 -
Effect of Anesthetics on Troponin I and С-reactive Protein
|
Phase 1 | |
Recruiting |
NCT02803957 -
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
|
N/A | |
Recruiting |
NCT04153292 -
The ENCIRCLE Trial
|
N/A | |
Completed |
NCT02607527 -
Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System
|
N/A | |
Active, not recruiting |
NCT03066050 -
Long Term Follow Up for CTSN Mitral Valve Repair Studies
|
||
Active, not recruiting |
NCT04443218 -
Edwards PASCAL Transcatheter Valve Repair System Registry
|
||
Enrolling by invitation |
NCT04067635 -
Primary Mitral Regurgitation Repair
|
||
Completed |
NCT01966146 -
Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI
|
N/A | |
Recruiting |
NCT01368575 -
Surgical Treatment of Ischemic Mitral Regurgitation
|
Phase 4 | |
Completed |
NCT00001314 -
Investigation of Heart Function in Patients With Heart Valve Defects
|
N/A | |
Terminated |
NCT03285724 -
Safety and Performance Study of the Harpoon Mitral Valve Repair System
|
N/A | |
Withdrawn |
NCT04709042 -
Acquisition of Objective Data During Transapical Neochordae Implantation
|
N/A |